{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:27:52Z","timestamp":1790666872535,"version":"4.1.0"},"reference-count":145,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Department of Pharmacology and Physiology, Georgetown University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s10571-015-0327-y","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T20:43:41Z","timestamp":1458333821000},"page":"259-279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"36","author":[{"given":"Juan M.","family":"Saavedra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,18]]},"reference":[{"key":"327_CR1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fmolb.2015.00054","volume":"2","author":"M Agrawal","year":"2015","unstructured":"Agrawal M, Biswas A (2015) Molecular diagnostics of neurodegenerative disorders. Front Mol Biosci 2:54. doi: 10.3389\/fmolb.2015.00054.eCollection","journal-title":"Front Mol Biosci"},{"key":"327_CR2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nm.3159","volume":"19","author":"M Ahmadian","year":"2013","unstructured":"Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M, Evans RM (2013) PPAR\u03b3 signaling and metabolism: the good, the bad and the future. Nat Med 19:557\u2013566. doi: 10.1038\/nm.3159","journal-title":"Nat Med"},{"key":"327_CR3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.arcmed.2013.12.005","volume":"45","author":"\u0150 Aky\u00fcrek","year":"2014","unstructured":"Aky\u00fcrek \u0150, Akbal E, G\u00fcnes F, Aky\u00fcrek N (2014) Peroxisome proliferator-activated receptor gamma concentrations in newly diagnosed hypertension patients and the metabolic effects of olmesartan. Arch Med Res 45:138\u2013142. doi: 10.1016\/j.arcmed.2013.12.00.005","journal-title":"Arch Med Res"},{"key":"327_CR4","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1515\/hsz-2013-0215","volume":"394","author":"S Aleshin","year":"2013","unstructured":"Aleshin S, Reiser G (2013) Role of the peroxisome proliferator-activated receptors (PPAR)-\u03b1, \u03b2\/\u03b4 and \u03b3 triad in regulation of reactive oxygen species signaling in brain. Biol Chem 394:1553\u20131570. doi: 10.1515\/hsz-2013-0215","journal-title":"Biol Chem"},{"key":"327_CR5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jalz.2013.02.003","volume":"9","author":"Alzheimer\u2019s Association","year":"2013","unstructured":"Alzheimer\u2019s Association (2013) Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement 9:208\u2013245. doi: 10.1016\/j.jalz.2013.02.003","journal-title":"Alzheimer\u2019s Dement"},{"key":"327_CR6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/hr.2010.79","volume":"33","author":"J An","year":"2010","unstructured":"An J, Nakajima T, Kuba K, Kimura A (2010) Losartan inhibits LPS-induced inflammatory signaling through a PPAR\u03b3-dependent mechanism in human THP-1 macrophages. Hypertens Res 33:831\u2013835. doi: 10.1038\/hr.2010.79","journal-title":"Hypertens Res"},{"key":"327_CR7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1474-4422(10)70250-7","volume":"10","author":"C Anderson","year":"2011","unstructured":"Anderson C, Teo K, Gao P, Arima H, Dans A, Unger T, Commerford P, Dyal L, Schumacher H, Pogue J, Paolasso E, Holwerda N, Chazova I, Binbrek A, Young J, Yusuf S, ONTARGET and TRANSCEND Investigators (2011) Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. Lancet Neurol 10:43\u201353. doi: 10.1016\/S1474-4422(10)70250-7","journal-title":"Lancet Neurol"},{"key":"327_CR8","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1161\/01.STR.0000129788.26346.18","volume":"35","author":"H Ando","year":"2004","unstructured":"Ando H, Zhou J, Macova M, Imboden H, Saavedra JM (2004) Angiotensin II AT1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats. Stroke 35:1726\u20131731. doi: 10.1161\/01.STR.0000129788.26346.18","journal-title":"Stroke"},{"key":"327_CR9","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archinternmed.2012.2091","volume":"172","author":"C Andrade","year":"2012","unstructured":"Andrade C, Fernandes P (2012) Do angiotensin receptor blockers really hold promise for the improvement of cognitive functioning? Arch Intern Med 172:1191\u20131192. doi: 10.1001\/archinternmed.2012.2091 author reply 1192","journal-title":"Arch Intern Med"},{"key":"327_CR10","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.lfs.2007.06.007","volume":"81","author":"GK Aulakh","year":"2007","unstructured":"Aulakh GK, Sodhi RK, Singh M (2007) An update on non-peptide angiotensin receptor antagonists and related RAAS modulators. Life Sci 81:615\u2013639. doi: 10.1016\/j.lfs.2007.06.007","journal-title":"Life Sci"},{"key":"327_CR11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev.pharmtox.010909.105610","volume":"50","author":"M Bader","year":"2010","unstructured":"Bader M (2010) Tissue renin-angiotensin-aldosterone systems: targets for pharmacological therapy. Ann Rev Phar Tox 50:439\u2013465. doi: 10.1146\/annurev.pharmtox.010909.105610","journal-title":"Ann Rev Phar Tox"},{"key":"327_CR128","doi-asserted-by":"crossref","unstructured":"Bakker ENTP, Bacskai BJ, Aldea R, Arbel-Omath M, Bedussi B, Morris AWJ, Weller RO, Carare RO (2016) Lymphatic clearance of the brain: perivascular, paravascular and significance for neurodegenerative diseases. Cell Mol Neurobiol. doi: 10.1007\/s10571-015-0273-8","DOI":"10.1007\/s10571-015-0273-8"},{"key":"327_CR12","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00005344-199008000-00009","volume":"16","author":"JM Barnes","year":"1990","unstructured":"Barnes JM, Barnes NM, Costall B, Horovitz ZP, Ironside JW, Naylor RJ, Williams TJ (1990) Angiotensin II inhibits cortical cholinergic function: implications for cognition. J Cardiovasc Pharmacol 16:234\u2013238","journal-title":"J Cardiovasc Pharmacol"},{"key":"327_CR13","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10571-009-9368-4","volume":"29","author":"J Benicky","year":"2009","unstructured":"Benicky J, S\u00e1nchez-Lemus E, Pavel J, Saavedra JM (2009) Anti-inflammatory effects of angiotensin receptor blockers in the brain and the periphery. Cell Mol Neurobiol 29:781\u2013792. doi: 10.1007\/s10571-009-9368-4","journal-title":"Cell Mol Neurobiol"},{"key":"327_CR14","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/npp.2010.225","volume":"36","author":"J Benicky","year":"2011","unstructured":"Benicky J, Sanchez-Lemus E, Honda M, Pang T, Orecna M, Wang J, Leng Y, Chuang DM, Saavedra JM (2011) Angiotensin II AT1 receptor blockade ameliorates brain inflammation. Neuropsychopharm 36:857\u2013870. doi: 10.1038\/npp.2010.225","journal-title":"Neuropsychopharm"},{"key":"327_CR15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","volume":"43","author":"SC Benson","year":"2004","unstructured":"Benson SC, Pershadsingh H, Ho C, Chittiboyina A, Desai P, Pravenec M, Qi N, Wang J, Avery M, Kurtz TW (2004) Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPAR\u03b3-modulating activity. Hypertension 43:993\u20131002. doi: 10.1161\/01.HYP.0000123072.34629.57","journal-title":"Hypertension"},{"key":"327_CR16","author":"MA Binnewijzend","year":"2015","unstructured":"Binnewijzend MA, Benedictus MR, Kuijer JP, van der Flier WM, Teunissen CE, Prins ND, Wattjes MP, van Berckel BN, Scheltens P, Barkhof F (2015) Cerebral perfusion in the predementia stages of Alzheimer\u2019s disease. Eur Radiol. doi: 10.1007\/s00330-015-3834-9","journal-title":"Eur Radiol"},{"key":"327_CR17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fnins.2015.00345","volume":"9","author":"K Blennow","year":"2015","unstructured":"Blennow K, Zetterberg H (2015) The past and the future of Alzheimer\u2019s disease CSF biomarkers-a journey toward validated biochemical tests covering the whole spectrum of molecular events. Front Neurosci 9:345. doi: 10.3389\/fnins.2015.00345.eCollection","journal-title":"Front Neurosci"},{"key":"327_CR18","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1681\/ASN.2012050536","volume":"24","author":"JM Bugnicourt","year":"2013","unstructured":"Bugnicourt JM, Godefroy O, Chillon JM, Choukroun G, Massy ZA (2013) Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. J Am Soc Nephrol 24:353\u2013363. doi: 10.1681\/ASN.2012050536","journal-title":"J Am Soc Nephrol"},{"key":"327_CR19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(99)10365-9","volume":"355","author":"M Burnier","year":"2000","unstructured":"Burnier M, Brunner HR (2000) Angiotensin II receptor antagonists. Lancet 355:637\u2013645. doi: 10.1016\/S0140-6736(99)10365-9","journal-title":"Lancet"},{"key":"327_CR20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/B978-0-12-800149-3.00005-6","volume":"87","author":"V Chouraki","year":"2014","unstructured":"Chouraki V, Seshadri S (2014) Genetics of Alzheimer\u2019s disease. Adv Genet 87:245\u2013294. doi: 10.1016\/B978-0-12-800149-3.00005-6","journal-title":"Adv Genet"},{"key":"327_CR21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/157488410791110742","volume":"5","author":"SG Chrysant","year":"2010","unstructured":"Chrysant SG, Chrysant GS, Chrysant C, Shiraz M (2010) The treatment of cardiovascular disease continuum: focus on prevention and RAS blockade. Curr Clin Pharmacol 5:89\u201395. doi: 10.2174\/157488410791110742","journal-title":"Curr Clin Pharmacol"},{"key":"327_CR22","doi-asserted-by":"crossref","first-page":"917","DOI":"10.4161\/auto.7.8.15813","volume":"7","author":"DF Dai","year":"2011","unstructured":"Dai DF, Rabinovitch P (2011) Mitochondrial oxidative stress mediates induction of autophagy and hypertrophy in angiotensin-II treated mouse hearts. Autophagy 7:917\u2013918. doi: 10.4161\/auto.7.8.15813","journal-title":"Autophagy"},{"key":"327_CR23","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1210\/jc.2002-021836","volume":"88","author":"P Dandona","year":"2003","unstructured":"Dandona P, Kumar V, Aljada A, Ghanim H, Syed T, Hofmayer D, Mohanty P, Tripathy D, Garg R (2003) Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an anti-inflammatory action. J Clin Endocrinol Metab 88:4496\u20134501. doi: 10.1210\/jc.2002-021836","journal-title":"J Clin Endocrinol Metab"},{"key":"327_CR24","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s11064-007-9337-6","volume":"32","author":"L Danielyan","year":"2007","unstructured":"Danielyan L, Lourhmati A, Verleysdonk S, Kabisch D, Proksch B, Thiess U, Umbreen S, Schmidt B, Gleiter CH (2007) Angiotensin receptor type 1 blockade in astroglia decreases hypoxia-induced cell damage and TNF\u03b1 release. Neurochem Res 32:1489\u20131498","journal-title":"Neurochem Res"},{"key":"327_CR25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/rej.2009.0944","volume":"13","author":"L Danielyan","year":"2010","unstructured":"Danielyan L, Klein R, Hanson LR, Buadze M, Schwab M, Gleiter CH, Frey WH (2010) Protective effects of intranasal losartan in the APP\/PS1 transgenic mouse model of Alzheimer disease. Rejuvenation Res 13:195\u2013201. doi: 10.1089\/rej.2009.0944","journal-title":"Rejuvenation Res"},{"key":"327_CR26","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s12640-013-9379-2","volume":"24","author":"MA Daulatzai","year":"2013","unstructured":"Daulatzai MA (2013) Death by a thousand cuts in Alzheimer\u2019s disease: Hypoxia-the prodrome. Neurotox Res 24:216\u2013243. doi: 10.1007\/s12640-013-9379-2","journal-title":"Neurotox Res"},{"key":"327_CR27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JAD-2011-110347","volume":"26","author":"NM Davies","year":"2011","unstructured":"Davies NM, Kehoe PG, Ben-Shlomo Y, Martin RM (2011) Associations of anti-hypertensive treatments with Alzheimer\u2019s disease, vascular dementia, and other dementias. J Alzheimers Dis 26:699\u2013708. doi: 10.3233\/JAD-2011-110347","journal-title":"J Alzheimers Dis"},{"key":"327_CR28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2174\/1567205010666131119234845","volume":"11","author":"AS Abeelen den","year":"2014","unstructured":"den Abeelen AS, Lagro J, van Beek AH, Claassen JA (2014) Impaired cerebral autoregulation and vasomotor reactivity in sporadic Alzheimer\u2019s disease. Curr Alzheimer Res 11:11\u201317. doi: 10.2174\/1567205010666131119234845","journal-title":"Curr Alzheimer Res"},{"key":"327_CR29","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S1474-4422(08)70198-4","volume":"7","author":"HC Diener","year":"2008","unstructured":"Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahl\u00f6f B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon BW, Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group Collaborators (1138) (2008) Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol 7:875\u2013884. doi: 10.1016\/S1474-4422(08)70198-4 Erratum in Lancet Neurol. 2008 Nov;7(11):985","journal-title":"Lancet Neurol"},{"key":"327_CR30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.neurobiolaging.2006.11.014","volume":"29","author":"JM Djordjevic","year":"2008","unstructured":"Djordjevic JM, Jones-Gotman K, De Sousa H, Chertkow H (2008) Olfaction in patients with mild cognitive impairment and Alzheimer\u2019s disease. Neurobiol Aging 29:693\u2013706. doi: 10.1016\/j.neurobiolaging.2006.11.014","journal-title":"Neurobiol Aging"},{"key":"327_CR31","doi-asserted-by":"crossref","unstructured":"Faraci FM, De Silva TM. (2016) Microvascular dysfunction and cognitive impairment. Cell Mol Neurobiol. doi: 10.1007\/s10571-015-0308-1","DOI":"10.1007\/s10571-015-0308-1"},{"key":"327_CR32","doi-asserted-by":"crossref","unstructured":"Faraco G, Park L, Zhou P, Luo W, Paul SM, Anrather J, Iadecola C (2015) Hypertension enhances A\u03b2-induced neurovascular dysfunction, promotes \u03b2-secretase activity, and leads to amyloidogenic processing of APP. J Cereb Blood Flow Metab. doi: 10.1038\/jcbfm.2015.79 . [Epub ahead of print]","DOI":"10.1038\/jcbfm.2015.79"},{"key":"327_CR33","first-page":"197","volume":"3","author":"L Ferrington","year":"2011","unstructured":"Ferrington L, Miners JS, Palmer LE, Bond SM, Povey JE, Kelly PA, Love S, Horsburgh KJ, Kehoe PG (2011) Angiotensin II-inhibiting drugs have no effect on intraneuronal A\u03b2 or oligomeric A\u03b2 levels in a triple transgenic mouse model of Alzheimer\u2019s disease. Am J Transl Res 3:197\u2013208","journal-title":"Am J Transl Res"},{"key":"327_CR34","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2174\/0929867321666140303143455","volume":"21","author":"M Fidaleo","year":"2014","unstructured":"Fidaleo M, Fanelli F, Ceru MP, Moreno S (2014) Neuroprotective properties of peroxisome proliferator-activated receptor alpha (PPAR\u03b1) and its lipid ligands. Curr Med Chem 21:2803\u20132821. doi: 10.2174\/0929867321666140303143455","journal-title":"Curr Med Chem"},{"key":"327_CR35","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/jcbfm.2008.158","volume":"29","author":"MA Fleegal-DeMotta","year":"2009","unstructured":"Fleegal-DeMotta MA, Doghu S, Banks WA (2009) Angiotensin II modulates BBB permeability via activation of the AT1 receptor in brain endothelial cells. J Cereb Blood Flow Metab 29:640\u2013647. doi: 10.1038\/jcbfm.2008.158","journal-title":"J Cereb Blood Flow Metab"},{"key":"327_CR36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.jhh.1001964","volume":"20","author":"R Fogari","year":"2006","unstructured":"Fogari R, Mugelline A, Zoppi A, Lazzari P, Destro M, Rinaldi A, Preti P (2006) Effect of telmisartan\/hydrochlorotiazide vs Lisinopril\/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. J Hum Hypertens 20:177\u2013185. doi: 10.1038\/sj.jhh.1001964","journal-title":"J Hum Hypertens"},{"key":"327_CR37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/HCO.0b013e3283620745","volume":"28","author":"I Hajjar","year":"2013","unstructured":"Hajjar I, Rodgers K (2013) Do angiotensin receptor blockers prevent Alzheimer\u2019s disease? Curr Opin Cardiol 28:417\u2013425. doi: 10.1097\/HCO.0b013e3283620745","journal-title":"Curr Opin Cardiol"},{"key":"327_CR38","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archneurol.2012.1010","volume":"69","author":"I Hajjar","year":"2012","unstructured":"Hajjar I, Brown L, Mack WJ, Chui H (2012) Impact of Angiotensin receptor blockers on Alzheimer disease neuropathology in a large brain autopsy series. Arch Neurol 69:1632\u20131638. doi: 10.1001\/archneurol.2012.1010","journal-title":"Arch Neurol"},{"key":"327_CR39","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/jgs.12100","volume":"61","author":"I Hajjar","year":"2013","unstructured":"Hajjar I, Hart M, Chen YL, Mack W, Novak V, Chui CH, Lipsitz L (2013) Antihypertensive therapy and cerebral hemodynamics in executive mild cognitive impairment: results of a pilot randomized clinical trial. J Am Geriatr Soc 61:194\u2013201. doi: 10.1111\/jgs.12100","journal-title":"J Am Geriatr Soc"},{"key":"327_CR40","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1468-1331.2007.01847.x","volume":"14","author":"H Hallevi","year":"2007","unstructured":"Hallevi H, Hazan-Halevy I, Paran E (2007) Modification of neutrophil adhesion to human endothelial cell line in acute ischemic stroke by dipyridamole and candesartan. Eur J Neurol 14:1002\u20131007. doi: 10.1111\/j.1468-1331.2007.01847.x","journal-title":"Eur J Neurol"},{"key":"327_CR129","doi-asserted-by":"crossref","unstructured":"Hamel E, Royea J, Ongali B Tong X-K (2016) Neurovascular and cognitive failure in Alzheimer\u2019s disease: benefits of cardiovascular therapy. Cell Mol Neurobiol. doi: 10.1007\/s10571-015-0285-4","DOI":"10.1007\/s10571-015-0285-4"},{"key":"327_CR41","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/hr.2014.51","volume":"37","author":"AU Hasan","year":"2014","unstructured":"Hasan AU, Ohmori K, Hashimoto T, Kamitori K, Yamaguchi F, Ishihara Y, Ishihara N, Noma T, Tokuda M, Kohno M (2014) Valsartan ameliorates the constitutive adipokine expression pattern in mature adipocytes: a role for inverse agonism of the angiotensin II type 1 receptor in obesity. Hypertens Res 37:621\u2013628. doi: 10.1038\/hr.2014.51","journal-title":"Hypertens Res"},{"key":"327_CR130","doi-asserted-by":"crossref","unstructured":"Hays CC, Zlatar ZZ, Wierenga CE (2016) The utility of cerebral blood flow as a biomarker of preclinical Alzheimer\u2019s disease. Cell Mol Neurobiol. doi: 10.1007\/s10571-015-0261-z","DOI":"10.1007\/s10571-015-0261-z"},{"key":"327_CR150","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbalip.2007.04.016","volume":"1771","author":"MT Heneka","year":"2007","unstructured":"Heneka MT, Landreth GE (2007) PPARs in the brain. Biochim Biophys Acta 1771:1031\u20131045. doi: 10.1016\/j.bbalip.2007.04.016","journal-title":"Biochim Biophys Acta"},{"key":"327_CR42","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2174\/157015911798376325","volume":"9","author":"MT Heneka","year":"2011","unstructured":"Heneka MT, Reyes-Irisarri E, H\u00fcll M, Kummer MP (2011) Impact and therapeutic potential of PPARs in Alzheimer\u2019s disease. Curr Neuropharmacol 9:643\u2013650. doi: 10.2174\/157015911798376325","journal-title":"Curr Neuropharmacol"},{"key":"327_CR43","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1476-5381.2010.01167.x","volume":"163","author":"M Horiuchi","year":"2011","unstructured":"Horiuchi M, Mogi M (2011) Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage. Br J Pharmacol 163:1122\u20131130. doi: 10.1111\/j.1476-5381.2010.01167.x","journal-title":"Br J Pharmacol"},{"key":"327_CR44","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1124\/mol.54.2.427","volume":"54","author":"L Hunyady","year":"1998","unstructured":"Hunyady L, Ji H, Jagadeesh G, Zhang M, G\u00e1borik Z, Mihalik B, Catt KJ (1998) Dependence of AT1 angiotensin receptor function on adjacent asparagine residues in the seventh transmembrane helix. Mol Pharm 54:427\u2013434. doi: 10.1124\/mol.54.2.427","journal-title":"Mol Pharm"},{"key":"327_CR45","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn1387","volume":"5","author":"C Iadecola","year":"2004","unstructured":"Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimer\u2019s disease. Nat Neurosci Rev 5:347\u2013360. doi: 10.1038\/nrn1387","journal-title":"Nat Neurosci Rev"},{"key":"327_CR46","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.neuron.2013.10.008","volume":"80","author":"C Iadecola","year":"2013","unstructured":"Iadecola C (2013) The pathobiology of vascular dementia. Neuron 80:844\u2013866. doi: 10.1016\/j.neuron.2013.10.008","journal-title":"Neuron"},{"key":"327_CR131","doi-asserted-by":"crossref","unstructured":"Iadecola C (2016) Vascular and metabolic factors in Alzheimer\u2019s diseases and related dementias: introduction. Cell Mol Neurobiol. doi: 10.1007\/s10571-015-0319-y","DOI":"10.1007\/s10571-015-0319-y"},{"key":"327_CR47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/brb3.13","volume":"1","author":"E Imabayashi","year":"2011","unstructured":"Imabayashi E, Matsuda H, Yoshimaru K, Kuji I, Seto A, Shimano Y, Ito K, Kikuta D, Shimazu T, Araki N (2011) Pilot data on telmisartan short-term effects on glucose metabolism in the olfactory tract in Alzheimer\u2019s disease. Brain Behav 1:63\u201369. doi: 10.1002\/brb3.13","journal-title":"Brain Behav"},{"key":"327_CR48","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/01.STR.0000027274.03779.F3","volume":"33","author":"T Ito","year":"2002","unstructured":"Ito T, Yamakawa H, Bregonzio C, Terr\u00f3n JA, Falc\u00f3n-Neri A, Saavedra JM (2002) Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic Pretreatment with an angiotensin II AT1 antagonist. Stroke 33:2297\u20132303. doi: 10.1161\/01.STR.0000027274.03779.F3","journal-title":"Stroke"},{"key":"327_CR49","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/hr.2008.27","volume":"32","author":"S Ito","year":"2009","unstructured":"Ito S, Nagasawa T, Abe M, Mori T (2009) Strain vessel hypothesis: viewpoint for linkage of albuminuria and cerebro-cardiovascular risk. Hypertens Res 32:115\u2013121. doi: 10.1038\/hr.2008.27","journal-title":"Hypertens Res"},{"key":"327_CR50","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/adip.21837","volume":"2","author":"M Iwashita","year":"2013","unstructured":"Iwashita M, Nakatsu Y, Sakoda H, Fujishiro M, Kushiyama A, Fukushima T, Kumamoto S, Shinjo T, Kamata H, Nishimura F, Asano T (2013) Valsartan restores inflammatory response by macrophages in adipose and hepatic tissues of LPS-infused mice. Adipocyte 2:28\u201332. doi: 10.4161\/adip.21837","journal-title":"Adipocyte"},{"key":"327_CR51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/alzrt230","volume":"5","author":"WA Jefferies","year":"2013","unstructured":"Jefferies WA, Price KA, Biron KE, Fenninger F, Pfeifer CG, Dickstein DL (2013) Adjusting the compass: new insights into the role of angiogenesis in Alzheimer\u2019s disease. Alzheimers Res Ther 5:64. doi: 10.1186\/alzrt230.eCollection","journal-title":"Alzheimers Res Ther"},{"key":"327_CR52","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jalz.2011.05.2414","volume":"8","author":"ML Johnson","year":"2012","unstructured":"Johnson ML, Parikh N, Kunik ME, Schulz PE, Patel JG, Chen H, Aparasu RR, Morgan RO (2012) Antihypertensive drug use and the risk of dementia in patients with diabetes mellitus. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc 8:437\u2013444. doi: 10.1016\/j.jalz.2011.05.2414","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"key":"327_CR53","first-page":"E104","volume":"271","author":"O J\u00f6hren","year":"1996","unstructured":"J\u00f6hren O, Saavedra JM (1996) Expression of AT1A and AT1B angiotensin II receptor messenger RNA in forebrain of 2-week-old rats. Am J Physiol 271:E104\u2013E112","journal-title":"Am J Physiol"},{"key":"327_CR54","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1124\/jpet.107.120097","volume":"322","author":"KH Jung","year":"2007","unstructured":"Jung KH, Chu K, Lee ST, Kim SJ, Song EC, Kim EH, Park DK, Sinn DI, Kim JM, Kim M, Roh JK (2007) Blockade of AT1 receptor reduces apoptosis, inflammation, and oxidative stress in normotensive rats with intracerebral hemorrhage. J Pharmacol Exp Ther 322:1051\u20131058. doi: 10.1124\/jpet.107.120097","journal-title":"J Pharmacol Exp Ther"},{"key":"327_CR55","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2133\/dmpk.22.267","volume":"22","author":"E Kamiyama","year":"2007","unstructured":"Kamiyama E, Yoshigae Y, Kasuya A, Takei M, Kurihara A, Ikeda T (2007) Inhibitory effects of angiotensin receptor blockers on CYP2C9 Activity in human liver microsomes. Drug Metab Pharmacokin 22:267\u2013275. doi: 10.2133\/dmpk.22.267","journal-title":"Drug Metab Pharmacokin"},{"key":"327_CR56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.brainres.2010.03.101","volume":"1340","author":"Y Kasahara","year":"2010","unstructured":"Kasahara Y, Taguchi A, Uno H, Nakano A, Nakagomi T, Hirose H, Stern DM, Matsuyama T (2010) Telmisartan suppresses cerebral injury in a murine model of transient focal ischemia. Brain Res 1340:70\u201380. doi: 10.1016\/j.brainres.2010.03.101","journal-title":"Brain Res"},{"key":"327_CR57","first-page":"197","volume":"3","author":"RJ Kelleher","year":"2013","unstructured":"Kelleher RJ, Soiza RL (2013) Evidence of endothelial dysfunction in the development of Alzheimer\u2019s disease: is Alzheimer\u2019s a vascular disorder? Am J Cardiovasc Dis 3:197\u2013226","journal-title":"Am J Cardiovasc Dis"},{"key":"327_CR58","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/bph.12229","volume":"169","author":"EJ Koh","year":"2013","unstructured":"Koh EJ, Yoon SJ, Lee SM (2013) Losartan protects liver against ischaemia\/reperfusion injury through PPAR-\u03b3 activation and receptor for advanced glycation end-products down-regulation. Br J Pharmacol 169:1404\u20131416. doi: 10.1111\/bph.12229","journal-title":"Br J Pharmacol"},{"key":"327_CR132","doi-asserted-by":"crossref","unstructured":"Koizumi K, Gang Wang G, Park L (2016) Endothelial dysfunction and amyloid-\u03b2-induced neurovascular alterations. Cell Mol Neurobiol. doi: 10.1007\/s10571-015-0256-9","DOI":"10.1007\/s10571-015-0256-9"},{"key":"327_CR59","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jns.2007.01.081","volume":"257","author":"AD Korczyn","year":"2007","unstructured":"Korczyn AD, Vakhapova V (2007) The prevention of the dementia epidemic. J Neurol Sci 257:2\u20134. doi: 10.1016\/j.jns.2007.01.081","journal-title":"J Neurol Sci"},{"key":"327_CR60","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/CS20120089","volume":"123","author":"R Kumar","year":"2012","unstructured":"Kumar R, Thomas CM, Yong QC, Chen W, Baker KM (2012) The intracrine renin-angiotensin system. Clin Sci (Lond) 123:273\u2013284. doi: 10.1042\/CS20120089","journal-title":"Clin Sci (Lond)"},{"key":"327_CR61","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1447-0594.2011.00746.x","volume":"12","author":"K Kume","year":"2012","unstructured":"Kume K, Hanyu H, Sakurai H, Takada Y, Onuma T, Iwamoto T (2012) Effects of telmisartan on cognition and regional cerebral blood flow in hypertensive patients with Alzheimer\u2019s disease. Geriatr Gerontol Int 12:207\u2013214. doi: 10.1111\/j.1447-0594.2011.00746.x","journal-title":"Geriatr Gerontol Int"},{"key":"327_CR62","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40266-013-0071-2","volume":"30","author":"H Kurinami","year":"2013","unstructured":"Kurinami H, Shimamura M, Sato N, Nakagami H, Morishita R (2013) Do angiotensin receptor blockers protect against Alzheimer\u2019s disease? Drugs Aging 30:367\u2013372. doi: 10.1007\/s40266-013-0071-2","journal-title":"Drugs Aging"},{"key":"327_CR63","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1172\/JCI41709","volume":"120","author":"TV Lanz","year":"2010","unstructured":"Lanz TV, Ding Z, Ho PP, Luo J, Agrawal AN, Srinagesh H, Axtell R, Zhang H, Platten M, Wyss-Coray T, Steinman L (2010) Angiotensin II sustains brain inflammation in mice via TGF-beta. J Clin Invest 120:2782\u20132794. doi: 10.1172\/JCI41709","journal-title":"J Clin Invest"},{"key":"327_CR64","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1097\/HJH.0b013e3283314bc7","volume":"27","author":"IM Larrayoz","year":"2009","unstructured":"Larrayoz IM, Pang T, Benicky J, Pavel J, S\u00e1nchez-Lemus E, Saavedra JM (2009) Candesartan reduces the innate immune response to lipopolysaccharide in human monocytes. J Hypertens 27:2365\u20132376. doi: 10.1097\/HJH.0b013e3283314bc7","journal-title":"J Hypertens"},{"key":"327_CR65","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/sj.bjp.0707323","volume":"151","author":"MT Le","year":"2007","unstructured":"Le MT, Pugsley MK, Vauquelin G, Van Liefde I (2007) Molecular characterization of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor. Br J Pharmacol 151:952\u2013962. doi: 10.1038\/sj.bjp.0707323","journal-title":"Br J Pharmacol"},{"key":"327_CR66","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/HJH.0b013e3283603f53","volume":"31","author":"N Levi Marpillat","year":"2013","unstructured":"Levi Marpillat N, Macquin-Mavier I, Tropeano AI, Bachoud-Levi AC, Maison P (2013) Antihypertensive classes, cognitive decline and incidence of dementia: a network meta-analysis. J Hypertens 31:1073\u20131082. doi: 10.1097\/HJH.0b013e3283603f53","journal-title":"J Hypertens"},{"key":"327_CR67","doi-asserted-by":"crossref","first-page":"b5465","DOI":"10.1136\/bmj.b5465","volume":"340","author":"NC Li","year":"2010","unstructured":"Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, Wolozin B (2010) Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ 340:b5465. doi: 10.1136\/bmj.b5465","journal-title":"BMJ"},{"key":"327_CR68","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2337\/db12-0570","volume":"62","author":"L Li","year":"2012","unstructured":"Li L, Luo Z, Yu H, Feng X, Wang P, Chen J, Pu Y, Zhao Y, He H, Zhong J, Liu D, Zhu Z (2012) Telmisartan improves insulin resistance of skeletal muscle through peroxisome proliferator-activated receptor-activation. Diabetes 62:762\u2013774. doi: 10.2337\/db12-0570","journal-title":"Diabetes"},{"key":"327_CR69","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.arr.2013.12.007","volume":"15","author":"L Liu","year":"2014","unstructured":"Liu L, Chan C (2014) The role of inflammasome in Alzheimer\u2019s disease. Ageing Res Rev 15:6\u201315. doi: 10.1016\/j.arr.2013.12.007","journal-title":"Ageing Res Rev"},{"key":"327_CR70","first-page":"5527","volume":"8","author":"T Ma","year":"2015","unstructured":"Ma T, Ma ZQ, Du XH, Yu QS, Wang R, Liu L (2015) Effect of valsartan on ACAT-1 and PPAR-\u03b3 expression in intima with carotid artery endothelial balloon injury in rabbit. Int J Clin Exp Med 8:5527\u20135533","journal-title":"Int J Clin Exp Med"},{"key":"327_CR71","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/00207450903389362","volume":"120","author":"S Matsumoto","year":"2010","unstructured":"Matsumoto S, Shimodozono M, Miyata R, Kawahira K (2010) The Angiotensin II type 1 receptor antagonist olmesartan preserves cerebral blood flow and cerebrovascular reserve capacity, and accelerates rehabilitative outcomes in hypertensive patients with a history of stroke. Int J Neurosci 120:372\u2013380. doi: 10.3109\/00207450903389362","journal-title":"Int J Neurosci"},{"key":"327_CR72","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/HYPERTENSIONAHA.112.192401","volume":"59","author":"LJ Min","year":"2012","unstructured":"Min LJ, Mogi M, Shudou M, Jing F, Tsukuda K, Ohshima K, Iwanami J, Horiuchi M (2012) Peroxisome proliferator-activated receptor-\u03b3 activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice. Hypertension 59:1079\u20131088. doi: 10.1161\/HYPERTENSIONAHA.112.192401","journal-title":"Hypertension"},{"key":"327_CR73","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/hr.2012.147","volume":"36","author":"S Miura","year":"2013","unstructured":"Miura S, Okabe A, Matsuo Y, Karnik SS, Saku K (2013) Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan. Hypert Res 36:134\u2013139. doi: 10.1038\/hr.2012.147","journal-title":"Hypert Res"},{"key":"327_CR74","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1460-9568.2007.06014.x","volume":"27","author":"M Miyoshi","year":"2008","unstructured":"Miyoshi M, Miyano K, Moriyama N, Taniguchi M, Watanabe T (2008) Angiotensin type 1 receptor antagonist inhibits lipopolysaccharide-induced stimulation of rat microglial cells by suppressing nuclear factor \u03baB and activator protein-1 activation. Eur J Neurosci 27:343\u2013351. doi: 10.1111\/j.1460-9568.2007.06014.x","journal-title":"Eur J Neurosci"},{"key":"327_CR75","doi-asserted-by":"crossref","unstructured":"Mogi M, Horiuchi M (2011) Clinical interaction between brain and kidney in small vessel disease. Cardiol Res Pract. 302189. doi: 10.4061\/2011\/306189","DOI":"10.4061\/2011\/306189"},{"key":"327_CR76","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bbrc.2008.08.032","volume":"375","author":"M Mogi","year":"2008","unstructured":"Mogi M, Li JM, Tsukuda K, Iwanami J, Min LJ, Sakata A, Fujita T, Iwai M, Horiuchi M (2008) Telmisartan prevented cognitive decline partly due to PPAR-gamma activation. Biochem Biophys Res Commun 375:446\u2013449. doi: 10.1016\/j.bbrc.2008.08.032","journal-title":"Biochem Biophys Res Commun"},{"key":"327_CR77","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bcp.2012.11.014","volume":"85","author":"K Mullane","year":"2013","unstructured":"Mullane K, Williams M (2013) Alzheimer\u2019s therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond? Biochem Pharm 85:289\u2013305. doi: 10.1016\/j.bcp.2012.11.014","journal-title":"Biochem Pharm"},{"key":"327_CR78","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3233\/JAD-140024","volume":"41","author":"L Nelson","year":"2014","unstructured":"Nelson L, Gard P, Tabet N (2014) Hypertension and inflammation in Alzheimer\u2019s disease: close partners in disease development and progression. J Alzheimer\u2019s Dis 41:331\u2013343. doi: 10.3233\/JAD-140024","journal-title":"J Alzheimer\u2019s Dis"},{"key":"327_CR79","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1161\/01.STR.31.10.2478","volume":"31","author":"Y Nishimura","year":"2000","unstructured":"Nishimura Y, Ito T, Saavedra JM (2000) Angiotensin II AT1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 31:2478\u20132486. doi: 10.1161\/01.STR.31.10.2478","journal-title":"Stroke"},{"key":"327_CR80","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.nucmedbio.2012.06.012","volume":"39","author":"A Noda","year":"2012","unstructured":"Noda A, Fushiki H, Murakami Y, Sasaki H, Miyoshi S, Kakuta H, Nishimura S (2012) Brain penetration of telmisartan, a unique centrally acting angiotensin II type 1 receptor blocker, studied by PET in conscious rhesus macaques. Nucl Med Biol 39:1232\u20131235. doi: 10.1016\/j.nucmedbio.2012.06.012","journal-title":"Nucl Med Biol"},{"key":"327_CR81","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1474-4422(10)70272-6","volume":"10","author":"AN Odili","year":"2011","unstructured":"Odili AN, Richart T, Staessen JA (2011) Methodological issues in the assessment of cognitive decline in ONTARGET and TRANSCEND. Lancet Neurol 10:22\u201324. doi: 10.1016\/S1474-4422(10)70272-6","journal-title":"Lancet Neurol"},{"key":"327_CR82","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4093\/dmj.2011.35.3.243","volume":"35","author":"SJ Oh","year":"2011","unstructured":"Oh SJ, Ha WC, Lee JI, Sohn TS, Kim JH, Lee JM, Chang SA, Hong OK, Son HS (2011) Angiotensin II inhibits insulin binding to endothelial cells. Diabetes Metab J 35:243\u2013247. doi: 10.4093\/dmj.2011.35.3.243","journal-title":"Diabetes Metab J"},{"key":"327_CR83","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.nbd.2014.04.018","volume":"68","author":"B Ongali","year":"2014","unstructured":"Ongali B, Nicolakakis N, Tong XK, Aboulkassim T, Papadopoulos P, Rosa-Neto P, Lecrux C, Imboden H, Hamel E (2014) Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer\u2019s disease model. Neurobiol Dis 68:126\u2013136. doi: 10.1016\/j.nbd.2014.04.018","journal-title":"Neurobiol Dis"},{"key":"327_CR84","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/s11064-007-9305-1","volume":"32","author":"VH Ozacmak","year":"2007","unstructured":"Ozacmak VH, Sayan H, Cetin A, Akyildiz-Igdem A (2007) AT1 receptor blocker candesartan-induced attenuation of brain injury of rats subjected to chronic cerebral hypoperfusion. Neurochem Res 32:1314\u20131321. doi: 10.1007\/s11064-007-9305-1","journal-title":"Neurochem Res"},{"key":"327_CR85","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/HJH.0b013e32834dde5f","volume":"30","author":"T Pang","year":"2012","unstructured":"Pang T, Benicky J, Wang J, Orecna M, Sanchez-Lemus E, Saavedra JM (2012a) Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-\u03b3 activation in human monocytes. J Hypertens 30:87\u201396. doi: 10.1097\/HJH.0b013e32834dde5f","journal-title":"J Hypertens"},{"key":"327_CR86","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1742-2094-9-102","volume":"9","author":"T Pang","year":"2012","unstructured":"Pang T, Wang J, Benicky J, S\u00e1nchez-Lemus E, Saavedra JM (2012b) Telmisartan directly ameliorates the neuronal inflammatory response to IL-1\u03b2 partly through the JNK\/c-Jun and NADPH oxidase pathways. J Neuroinflammation 9:102. doi: 10.1186\/1742-2094-9-102","journal-title":"J Neuroinflammation"},{"key":"327_CR87","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/aps.2013.199","volume":"35","author":"T Pang","year":"2014","unstructured":"Pang T, Sun LX, Wang T, Jiang ZZ, Liao H, Zhang LY (2014) Telmisartan protects central neurons against nutrient deprivation-induced apoptosis in vitro through activation of PPAR\u03b3 and the Akt\/GSK-3\u03b2 pathway. Acta Pharmacol Sin 35:727\u2013737. doi: 10.1038\/aps.2013.199","journal-title":"Acta Pharmacol Sin"},{"key":"327_CR88","first-page":"231","volume":"28","author":"OB Paulson","year":"1991","unstructured":"Paulson OB, Waldemar G (1991) Role of the local renin-angiotensin system in the autoregulation of the cerebral circulation. Blood Vessels 28:231\u2013235","journal-title":"Blood Vessels"},{"key":"327_CR89","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2174\/15734021113099990003","volume":"9","author":"N Pelisch","year":"2013","unstructured":"Pelisch N, Hosomi N, Mori H, Masaki T, Nishiyama A (2013) RAS inhibition attenuates cognitive impairment by reducing blood- brain barrier permeability in hypertensive subjects. Curr Hypertens Rev 9:93\u201398. doi: 10.2174\/15734021113099990003","journal-title":"Curr Hypertens Rev"},{"issue":"e95413","key":"327_CR90","first-page":"2014","volume":"9","author":"E P\u00e9rez-Palma","year":"2014","unstructured":"P\u00e9rez-Palma E, Bustos BI, Villam\u00e1n CF, Alarc\u00f3n MA, Avila ME, Ugarte GD, Reyes AE, Opazo C, De Ferrari GV, Alzheimer\u2019s Disease Neuroimaging Initiative, NIA-LOAD\/NCRAD Family Study Group. Collaborators (448) (2014) Overrepresentation of glutamate signaling in Alzheimer\u2019s disease: network-based pathway enrichment using meta-analysis of genome-wide association studies. PLoS One 9(e95413):2014. doi: 10.1371\/journal.pone.0095413.eCollection","journal-title":"PLoS One"},{"key":"327_CR91","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2015.08.007","volume":"81","author":"DG Peters","year":"2015","unstructured":"Peters DG, Connor JR, Meadowcroft MD (2015) The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer\u2019s disease: two sides of the same coin. Neurobiol Dis 81:49\u201365. doi: 10.1016\/j.nbd.2015.08.007","journal-title":"Neurobiol Dis"},{"key":"327_CR92","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/WNN.0000000000000071","volume":"28","author":"O Pletnikova","year":"2015","unstructured":"Pletnikova O, Rudow GL, Hyde TM, Kleinman JE, Ali SZ, Bharadwaj R, Gangadeen S, Crain BJ, Fowler DR, Rubio AI, Troncoso JC (2015) Alzheimer lesions in the autopsied brains of people 30\u201350 years of age. Cogn Behav Neurol 28:144\u2013152. doi: 10.1097\/WNN.0000000000000071","journal-title":"Cogn Behav Neurol"},{"key":"327_CR93","doi-asserted-by":"crossref","first-page":"768594","DOI":"10.1155\/2014\/768594","volume":"2014","author":"RA Quintanilla","year":"2014","unstructured":"Quintanilla RA, Utreras E, Cabezas-Opazo FA (2014) Role of PPAR \u03b3 in the differentiation and function of neurons. PPAR Res 2014:768594. doi: 10.1155\/2014\/768594","journal-title":"PPAR Res"},{"key":"327_CR94","unstructured":"Renin-Angiotensin-Aldosterone System in the Cardiovascular System and Beyond series of reviews at http:\/\/www.clinsci.org\/cs\/RAAScollection.htm , 2013"},{"key":"327_CR95","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2174\/1567205011666140131121739","volume":"11","author":"C Richardson","year":"2014","unstructured":"Richardson C, Nilforooshan R, Gard PR, Weaving G, Tabet N (2014) Impaired renal function and biomarkers of vascular disease in Alzheimer\u2019s disease. Curr Alzheimer Res 11:253\u2013258. doi: 10.2174\/1567205011666140131121739","journal-title":"Curr Alzheimer Res"},{"key":"327_CR96","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijrobp.2008.09.058","volume":"73","author":"ME Robbins","year":"2009","unstructured":"Robbins ME, Payne V, Tommasi E, Diz DI, Hsu FC, Brown WR, Wheeler KT, Olson J, Zhao W (2009) The AT1 receptor antagonist, L-158,809, prevents or ameliorates fractionated whole-brain irradiation-induced cognitive impairment. Int J Radiat Oncol Biol Phys 73:499\u2013505. doi: 10.1016\/j.ijrobp.2008.09.058","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"327_CR97","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1042\/CS20120078","volume":"123","author":"JM Saavedra","year":"2012","unstructured":"Saavedra JM (2012a) Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders. Clin Sci (Lond) 123:567\u2013590. doi: 10.1042\/CS20120078","journal-title":"Clin Sci (Lond)"},{"key":"327_CR98","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10571-011-9754-6","volume":"32","author":"JM Saavedra","year":"2012","unstructured":"Saavedra JM (2012b) Angiotensin II AT(1) receptor blockers ameliorate inflammatory stress: a beneficial effect for the treatment of brain disorders. Cell Mol Neurobiol 32:667\u2013681. doi: 10.1007\/s10571-011-9754-6","journal-title":"Cell Mol Neurobiol"},{"key":"327_CR99","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3233\/JAD-150274","volume":"48","author":"M Samuraki","year":"2015","unstructured":"Samuraki M, Matsunari I, Yoshita M, Shima K, Noguchi-Shinohara M, Hamaguchi T, Ono K, Yamada M (2015) Cerebral amyloid angiopathy-related microbleeds correlate with glucose metabolism and brain volume in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 48:517\u2013528. doi: 10.3233\/JAD-150274","journal-title":"J Alzheimer\u2019s Dis"},{"key":"327_CR100","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1161\/HYPERTENSIONAHA.107.104570","volume":"51","author":"F Scalera","year":"2008","unstructured":"Scalera F, Martens-Lobenhoffer J, Bukowska A, Lendeckel U, T\u00e4ger M, Bode-B\u00f6ger SM (2008) Effect of telmisartan on nitric oxide\u2013asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor and peroxisome proliferator activated receptor gamma signaling during endothelial aging. Hypertension 51:696\u2013703. doi: 10.1161\/HYPERTENSIONAHA.107.104570","journal-title":"Hypertension"},{"key":"327_CR101","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.0000127955.36250.65","volume":"109","author":"M Schupp","year":"2004","unstructured":"Schupp M, Janke J, Clasen R, Unger T, Kintscher U (2004) Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity. Circulation 109:2054\u20132057. doi: 10.1161\/01.CIR.0000127955.36250.65","journal-title":"Circulation"},{"key":"327_CR102","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.nucmedbio.2012.01.008","volume":"39","author":"K Shimizu","year":"2012","unstructured":"Shimizu K, Takashima T, Yamane T, Sasaki M, Kageyama H, Hashizume Y, Maeda K, Sugiyama Y, Watanabe Y, Senda M (2012) Whole-body distribution and radiation dosimetry of [11C]telmisartan as a biomarker for hepatic organic anion transporting polypeptide (OATP) 1B3. Nucl Med Biol 39:847\u2013853. doi: 10.1016\/j.nucmedbio.2012.01.008","journal-title":"Nucl Med Biol"},{"key":"327_CR103","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2165\/00003088-200544080-00003","volume":"44","author":"DA Sica","year":"2005","unstructured":"Sica DA, Gehr TW, Ghosh S (2005) Clinical pharmacokinetics of losartan. Clin Pharmacokinet 44:797\u2013814. doi: 10.2165\/00003088-200544080-00003","journal-title":"Clin Pharmacokinet"},{"key":"327_CR104","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1179\/016164103101201986","volume":"25","author":"I Skoog","year":"2003","unstructured":"Skoog I, Gustafson D (2003) Hypertension, hypertension-clustering factors and Alzheimer\u2019s disease. Neurol Res 25:675\u2013680. doi: 10.1179\/016164103101201986","journal-title":"Neurol Res"},{"key":"327_CR105","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.amjhyper.2005.02.013","volume":"18","author":"I Skoog","year":"2005","unstructured":"Skoog I, Lithell H, Hansson L, Elmfeldt D, Hofman A, Olsson B, Trenkwalder P, Zanchetti A, SCOPE Study Group (2005) Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE). Am J Hypertens 18:1052\u20131059. doi: 10.1016\/j.amjhyper.2005.02.013","journal-title":"Am J Hypertens"},{"key":"327_CR106","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.peptides.2009.07.003","volume":"30","author":"R Skrbic","year":"2009","unstructured":"Skrbic R, Igic R (2009) Seven decades of angiotensin (1939\u20132009). Peptides 30:1945\u20131950. doi: 10.1016\/j.peptides.2009.07.003","journal-title":"Peptides"},{"key":"327_CR107","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jalz.2014.10.008","volume":"11","author":"HM Snyder","year":"2015","unstructured":"Snyder HM, Corriveau RA, Craft S, Faber JE, Greenberg SM, Knopman D, Lamb BT, Montine TJ, Nedergaard M, Schaffer CB, Schneider JA, Wellington C, Wilcock DM, Zipfel GJ, Zlokovic B, Bain LJ, Bosetti F, Galis ZS, Koroshetz W, Carrillo MC (2015) Vascular contributions to cognitive impairment and dementia including Alzheimer\u2019s disease. Alzheimers Dement 11:710\u2013717. doi: 10.1016\/j.jalz.2014.10.008","journal-title":"Alzheimers Dement"},{"key":"327_CR108","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.bbrc.2013.08.091","volume":"439","author":"YI Sohn","year":"2013","unstructured":"Sohn YI, Lee NJ, Chung A, Saavedra JM, Turner RS, Pak DTS, Hoe H-S (2013) Antihypertensive drug Valsartan promotes dendritic spine density by altering AMPA receptor trafficking. Biochem Biophys Res Commun 439:464\u2013470. doi: 10.1016\/j.bbrc.2013.08.091","journal-title":"Biochem Biophys Res Commun"},{"key":"327_CR200","first-page":"171","volume":"6","author":"S Takeda","year":"2014","unstructured":"Takeda S, Sato N, Morishita R (2014) Systemic inflammation, blood-brain barrier vulnerability and cognitive\/non-cognitive symptoms in Alzheimer\u2019s disease: relevance to pathogenesis and therapy. Front Aging Neurosci 6:171. doi: 10.3389\/fnagi.2014.00171 .","journal-title":"Front Aging Neurosci"},{"key":"327_CR109","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/HYPERTENSIONAHA.109.138586","volume":"54","author":"S Takeda","year":"2009","unstructured":"Takeda S, Sato N, Takeuchi D, Kurinami H, Shinohara M, Niisato K, Kano M, Ogihara T, Rakugi H, Morishita R (2009) Angiotensin receptor blocker prevented \u03b2-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling. Hypertension 54:1345\u20131352. doi: 10.1161\/HYPERTENSIONAHA.109.138586 .","journal-title":"Hypertension"},{"key":"327_CR110","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0895-7061(99)00156-9","volume":"12","author":"MA Tedesco","year":"1999","unstructured":"Tedesco MA, Ratti G, Mennella S, Manzo G, Grieco M, Rainone AC, Iarussi D, Iacono A (1999) Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients. Am J Hypertens 12:1130\u20131134. doi: 10.1016\/S0895-7061(99)00156-9","journal-title":"Am J Hypertens"},{"key":"327_CR111","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/CCM.0b013e31822f08b9","volume":"40","author":"R Timaru-Kast","year":"2012","unstructured":"Timaru-Kast R, Wyschkon S, Luh C, Schaible EV, Lehmann F, Merk P, Werner C, Engelhard K, Thal SC (2012) Delayed inhibition of angiotensin II receptor type 1 reduces secondary brain damage and improves functional recovery after experimental brain trauma. Crit Care Med 40:935\u2013944. doi: 10.1097\/CCM.0b013e31822f08b9","journal-title":"Crit Care Med"},{"key":"327_CR112","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbr.2008.11.044","volume":"199","author":"S Tota","year":"2009","unstructured":"Tota S, Kamat PK, Awasthi H, Singh N, Raghubir R, Nath C, Hanif K (2009) Candesartan improves memory decline in mice: involvement of AT1 receptors in memory deficit induced by intracerebral streptozotocin. Behav Brain Res 199:235\u2013240. doi: 10.1016\/j.bbr.2008.11.044","journal-title":"Behav Brain Res"},{"key":"327_CR113","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00213-012-2639-7","volume":"222","author":"S Tota","year":"2012","unstructured":"Tota S, Hanif K, Kamat PK, Najmi AK, Nath C (2012) Role of central angiotensin receptors in scopolamine-induced impairment in memory, cerebral blood flow, and cholinergic function. Psychopharmacol (Berl) 222:185\u2013202. doi: 10.1007\/s00213-012-2639-7","journal-title":"Psychopharmacol (Berl)"},{"key":"327_CR114","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/00004872-200406000-00015","volume":"22","author":"RM Touyz","year":"2004","unstructured":"Touyz RM, Yao G, Viel E, Amiri F, Schiffrin EL (2004) Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. J Hypertens 22:1141\u20131149","journal-title":"J Hypertens"},{"key":"327_CR115","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/HYPERTENSIONAHA.109.136879","volume":"54","author":"K Tsukuda","year":"2009","unstructured":"Tsukuda K, Mogi M, Iwanami J, Min LJ, Sakata A, Jing F, Iwai M, Horiuchi M (2009) Cognitive deficit in amyloid-\u03b2-injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor-\u03b3 activation. Hypertension 54:782\u2013787. doi: 10.1161\/HYPERTENSIONAHA.109.136879","journal-title":"Hypertension"},{"key":"327_CR116","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ajh\/hpu197","volume":"28","author":"S Villapol","year":"2015","unstructured":"Villapol S, Saavedra JM (2015) Neuroprotective effects of angiotensin receptor blockers. Am J Hypertens 28:289\u2013299. doi: 10.1093\/ajh\/hpu197","journal-title":"Am J Hypertens"},{"key":"327_CR117","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1038\/npp.2012.152","volume":"37","author":"S Villapol","year":"2012","unstructured":"Villapol S, Yaszemski AK, Logan TT, S\u00e1nchez-Lemus E, Saavedra JM, Symes AJ (2012) Candesartan, an angiotensin II AT1-receptor blocker and PPAR-\u03b3 agonist, reduces lesion volume and improves motor and memory function after traumatic brain injury in mice. Neuropsychopharmacol 37:2817\u20132829. doi: 10.1038\/npp.2012.152","journal-title":"Neuropsychopharmacol"},{"key":"327_CR118","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1093\/brain\/awv172","volume":"138","author":"S Villapol","year":"2015","unstructured":"Villapol S, Balarezo MG, Affram K, Saavedra JM, Symes AJ (2015) Neurorestoration after traumatic brain injury through angiotensin II receptor blockage. Brain 138:3299\u20133315. doi: 10.1093\/brain\/awv172","journal-title":"Brain"},{"key":"327_CR119","first-page":"755","volume":"13","author":"T Vraamak","year":"1995","unstructured":"Vraamak T, Waldemar G, Stradgaard S, Paulson S (1995) Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation. J Hypertens 13:755\u2013761","journal-title":"J Hypertens"},{"key":"327_CR120","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1172\/JCI31547","volume":"117","author":"J Wang","year":"2007","unstructured":"Wang J, Ho L, Chen L, Zhao Z, Zhao W, Qian X, Humala N, Seror I, Bartholomew S, Rosendorff C, Pasinetti GM (2007) Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. J Clin Invest 117:3393\u20133402. doi: 10.1172\/JCI31547","journal-title":"J Clin Invest"},{"key":"327_CR121","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.neuropharm.2013.11.022","volume":"79","author":"J Wang","year":"2014","unstructured":"Wang J, Pang T, Hafko R, Benicky J, Sanchez-Lemus E, Saavedra JM (2014) Telmisartan ameliorates glutamate-induced neurotoxicity: roles of AT(1) receptor blockade and PPAR\u03b3 activation. Neuropharmacol 79:249\u2013261. doi: 10.1016\/j.neuropharm.2013.11.022","journal-title":"Neuropharmacol"},{"key":"327_CR122","doi-asserted-by":"crossref","unstructured":"Washington PM, Villapol S, Burns MP (2015) Polypathology and dementia after brain trauma: does brain injury trigger distinct neurodegenerative diseases, or should they be classified together as traumatic encephalopathy? Exp Neurol. doi: 10.1016\/j.expneurol.2015.06.015","DOI":"10.1016\/j.expneurol.2015.06.015"},{"key":"327_CR123","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0091-3057(93)90265-U","volume":"45","author":"MJ Wayner","year":"1993","unstructured":"Wayner MJ, Armstrong DL, Polan-Curtain JL, Denny JB (1993) Role of angiotensin II and AT1 receptors in hippocampal LTP. Pharmacol Biochem Behav 45:455\u2013464. doi: 10.1016\/0091-3057(93)90265-U","journal-title":"Pharmacol Biochem Behav"},{"key":"327_CR124","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/1470320314526269","volume":"16","author":"D Wincewicz","year":"2015","unstructured":"Wincewicz D, Braszko JJ (2015) Angiotensin II AT1 receptor blockade by telmisartan reduces impairment of spatial maze performance induced by both acute and chronic stress. J Renin Angiotensin Aldosterone Syst 16:495\u2013505. doi: 10.1177\/1470320314526269","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"327_CR125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1476-5381.2010.00840.x","volume":"161","author":"X Wu","year":"2010","unstructured":"Wu X, Kihara T, Hongo H, Akaike A, Niidome T, Sugimoto H (2010) Angiotensin receptor type 1 antagonists protect against neuronal injury induced by oxygen-glucose depletion. Br J Pharmacol 161:33\u201350. doi: 10.1111\/j.1476-5381.2010.00840.x","journal-title":"Br J Pharmacol"},{"key":"327_CR126","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0002-9440(10)64713-X","volume":"156","author":"T Wyss-Coray","year":"2000","unstructured":"Wyss-Coray T, Lin C, Sanan DA, Mucke L, Masliah E (2000) Chronic overproduction of transforming growth factor-beta 1 by astrocytes promotes Alzheimer\u2019s disease-like microvascular degeneration in transgenic mice. Am J Pathol 156:139\u2013150. doi: 10.1016\/S0002-9440(10)64713-X","journal-title":"Am J Pathol"},{"key":"327_CR127","doi-asserted-by":"crossref","unstructured":"Xu Y, Xu Y, Wang Y, Wang Y, He L, Jiang Z, Huang Z, Liao H, Li J, Saavedra JM, Zhang L, Pang T (2015) Telmisartan prevention of LPS-induced microglia activation involves M2 microglia polarization via CaMKK\u03b2-dependent AMPK activation. Brain Behav Immun. doi: 10.1016\/j.bbi.2015.07.015","DOI":"10.1016\/j.bbi.2015.07.015"},{"key":"327_CR133","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.WCB.0000047369.05600.03","volume":"23","author":"H Yamakawa","year":"2003","unstructured":"Yamakawa H, Jezova M, Ando H, Saavedra JM (2003) Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition. J Cereb Blood Flow Metab 23:371\u2013380","journal-title":"J Cereb Blood Flow Metab"},{"key":"327_CR134","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1212\/WNL.0b013e3182a35228","volume":"81","author":"S Yasar","year":"2013","unstructured":"Yasar S, Xia JJ, Yao W, Furberg CD, Xue QL, Mercado CI, Fitzpatrick AL, Fried LP, Kawas CH, Sink KM, Williamson KM, DeKosky ST, Carlson MC, Ginkgo Evaluation of Memory (GEM) Study Investigators (2013) Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo evaluation of memory study. Neurology 81:896\u2013903. doi: 10.1212\/WNL.0b013e3182a35228","journal-title":"Neurology"},{"key":"327_CR135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/08037050600771583","volume":"15","author":"A Zanchetti","year":"2006","unstructured":"Zanchetti A, Elmfeldt D (2006) Findings and implications of the Study on COgnition and Prognosis in the Elderly (SCOPE)\u2014a review. Blood Press 15:71\u201379. doi: 10.1080\/08037050600771583","journal-title":"Blood Press"},{"key":"327_CR136","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.neuroscience.2010.09.029","volume":"171","author":"M Zhang","year":"2010","unstructured":"Zhang M, Mao Y, Ramirez SH, Tuma RF, Chabrashvili T (2010) Angiotensin II induced cerebral microvascular inflammation and increased blood-brain barrier permeability via oxidative stress. Neuroscience 171:852\u2013858. doi: 10.1016\/j.neuroscience.2010.09.029","journal-title":"Neuroscience"},{"key":"327_CR137","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1463-1326.2011.01471.x","volume":"13","author":"M Zhao","year":"2011","unstructured":"Zhao M, Li Y, Wang J, Ebihara K, Rong X, Hosoda K, Tomita T, Nakao K (2011) Azilsartan treatment improves insulin sensitivity in obese spontaneously hypertensive Koletsky rats. Diabetes Obes Metab 13:1123\u20131129. doi: 10.1111\/j.1463-1326.2011.01471.x","journal-title":"Diabetes Obes Metab"},{"key":"327_CR138","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/sj.jcbfm.9600082","volume":"25","author":"J Zhou","year":"2005","unstructured":"Zhou J, Ando H, Macova M, Dou J, Saavedra JM (2005) Angiotensin II AT1 receptor blockade abolishes brain microvascular inflammation and heat shock protein responses in hypertensive rats. J Cereb Blood Flow Metab 25:878\u2013886. doi: 10.1038\/sj.jcbfm.9600082","journal-title":"J Cereb Blood Flow Metab"},{"key":"327_CR139","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1161\/01.STR.0000217404.64352.d7","volume":"37","author":"J Zhou","year":"2006","unstructured":"Zhou J, Pavel J, Macova M, Yu ZX, Imboden H, Ge L, Nishioku T, Dou J, Delgiacco E, Saavedra JM (2006) AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats. Stroke 37:1271\u20131276. doi: 10.1161\/01.STR.0000217404.64352.d7","journal-title":"Stroke"},{"key":"327_CR140","doi-asserted-by":"crossref","first-page":"e16037","DOI":"10.1371\/journal.pone.0016037","volume":"6","author":"D Zhu","year":"2011","unstructured":"Zhu D, Shi J, Zhang Y, Wang B, Liu W, Chen Z, Tong Q (2011) Central angiotensin II stimulation promotes \u03b2 amyloid production in Sprague Dawley rats. PLoS ONE 6:e16037. doi: 10.1371\/journal.pone.0016037","journal-title":"PLoS ONE"},{"key":"327_CR141","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fnagi.2014.00176","volume":"6","author":"JM Zolezzi","year":"2014","unstructured":"Zolezzi JM, Bast\u00edas-Candia S, Santos MJ, Inestrosa NC (2014) Alzheimer\u2019s disease: relevant molecular and physiopathological events affecting amyloid-\u03b2 brain balance and the putative role of PPARs. Front Aging Neurosci 6:176. doi: 10.3389\/fnagi.2014.00176","journal-title":"Front Aging Neurosci"},{"key":"327_CR142","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2006.08.062","volume":"552","author":"S Zorad","year":"2006","unstructured":"Zorad S, Dou JT, Benicky J, Hutanu D, Tybitanclova K, Zhou J, Saavedra JM (2006) Long-term angiotensin II AT1 receptor inhibition produces adipose tissue hypotrophy accompanied by increased expression of adiponectin and PPARgamma. Eur J Pharmacol 552:112\u2013122. doi: 10.1016\/j.ejphar.2006.08.062","journal-title":"Eur J Pharmacol"},{"key":"327_CR143","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0895-7061(99)00116-8","volume":"12","author":"RM Zusman","year":"1999","unstructured":"Zusman RM, Jullien V, Lemetayer P, Jarnier P, Clementy J (1999) Are there differences among angiotensin receptor blockers? Am J Hypertens 12:231\u2013235. doi: 10.1016\/S0895-7061(99)00116-8","journal-title":"Am J Hypertens"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-015-0327-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10571-015-0327-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-015-0327-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T16:06:47Z","timestamp":1655309207000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10571-015-0327-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":145,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["327"],"URL":"https:\/\/doi.org\/10.1007\/s10571-015-0327-y","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}